![]() |
市场调查报告书
商品编码
1542927
全球外鼻扩张器市场 - 2024-2031Global External Nasal Dilator Market - 2024-2031 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
2023年,全球外鼻扩张器市场达到1.798亿美元,预计2031年将达到2.7322亿美元,2024-2031年预测期间复合年增长率为5.5%。
外鼻扩张器 (END) 是包含中央鬆紧带的黏合带,可透过防止外侧鼻前庭塌陷来减少鼻阻力和吸气压力。 END 水平涂抹于鼻背皮肤。
外鼻扩张器是塑胶或硅胶装置。它是 2 条带有弹簧状带的黏合剂,透过抬起并保持鼻子两侧打开来扩张鼻道。此动作可减少鼻气道阻力并改善气流。
由于打鼾、睡眠相关疾病和鼻塞的盛行率不断增加,以及该领域对非侵入性治疗解决方案的需求,外鼻扩张器的市场可能会成长。
司机
人们对打鼾和睡眠障碍的认识不断提高
有几个因素影响了全球外鼻扩张器市场的整体需求。随着打鼾和睡眠障碍对健康的风险越来越为人所知,人们正在寻找在非侵入性睡眠时更好地呼吸的方法。外鼻扩张器的进步被认为是减少打鼾和促进呼吸的工具,有助于市场成长。
许多人寻求非侵入性方法来解决与前方呼吸有关的问题,例如鼻塞和呼吸困难。外鼻扩张器是简单且非手术的选择,可移动鼻孔开口区域以减少鼻呼吸困难。
此外,美国主要参与者推出新的意识计划将推动该市场的成长。 2023 年 2 月,美国睡眠医学会发起了「不仅仅是打鼾」活动,以提高人们对阻塞性睡眠呼吸中止症和打鼾的认识。该活动旨在提高全国对睡眠呼吸中止症的认识,并鼓励未确诊的患者为自己及其治疗辩护。
此外,运动员和锻炼身体以提高成绩的人经常使用鼻扩张器。这些条带被认为可以促进氧气摄入和通气,从而增强耐力和整体表现。
一般来说,外鼻扩张器使用简单,不需要任何特殊训练或药物治疗。它们的吸引力归因于它们的便利性,因为消费者无需专家指导即可实施它们。非处方外鼻扩张器在药局、杂货店和线上零售商处随处可见。对于任何寻求缓解鼻塞和相关问题的人来说,它们是一个实用的选择,因为它们易于使用。
限制
诸如设备成本高、扩张器缺乏可重复使用性、粘合剂刺激皮肤引起的不适、缺乏认识和采用、替代解决方案的竞争、产品选择有限以及它们对某些类型的打鼾效果有限等因素预计将阻碍市场。
The Global External Nasal Dilators Market reached US$ 179.80 million in 2023 and is expected to reach US$ 273.22 million by 2031, growing at a CAGR of 5.5% during the forecast period 2024-2031.
External nasal dilators (ENDs) are adhesive bands containing a central elastic strip that reduce nasal resistance and inspiratory pressure by preventing the collapse of the lateral nasal vestibule. ENDs are applied horizontally to the skin of the nasal dorsum.
The external nasal dilator is a plastic or silicone device. It is 2 strips of adhesive with spring-like bands that expand the nasal passages by lifting and holding open the sides of the nose. This action decreases nasal airway resistance and allows improved airflow.
The market for external nasal dilators is likely to grow due to the increasing prevalence of snoring, sleep-related disorders & clogged noses among people as well as the demand for non-invasive treatment solutions in this area.
Market Dynamics: Drivers
Growing Awareness of Snoring and Sleep Disorders
Several factors contribute to the overall demand for the global external nasal dilator market. As the risks of snoring and sleep disorders to health become more widely known, people are looking for ways to breathe better while they sleep non-invasively. Advancements in external nasal dilators are advocated as tools to decrease snoring and facilitate respiration, contributing to market growth.
A lot of people look for non-invasive methods to deal with problems concerning breathing in ahead such as nasal congestion and restriction. External nasal dilators are simple and non-surgical options to move the area of the nostrils opening to reduce nasal breathing difficulties.
Moreover, major players in the U.S. introducing the new awareness program would propel this market growth. In February 2023, the American Academy of Sleep Medicine launched "More than a Snore" to raise awareness of obstructive sleep apnea and snoring. This campaign aims to raise national awareness of sleep apnea and encourage undiagnosed patients to advocate for themselves and their treatment.
In addition, nasal dilators are frequently used by athletes and those who exercise to improve their performance. These strips are thought to promote oxygen intake and ventilation, which could enhance endurance and general performance.
In general, external nasal dilators are simple to use and don't involve any special training or medication. Their appeal is attributed to their convenience since consumers can implement them without requiring expert guidance. The over-the-counter versions of external nasal dilators are widely accessible in pharmacies, grocery stores, and online retailers. They are a practical option for anyone looking for relief from nasal congestion and related problems because of their easy accessibility.
Restraints
Factors such as the high cost of the devices, lack of reusability of dilators, discomfort due to skin irritation from the adhesive, lack of awareness and adoption, competition from alternative solutions, limited product options, and their limited effectiveness for certain types of snoring these are expected to hamper the market.
The global external nasal dilator market is segmented based on product type, application, age group, sales channel, and region.
The nasal congestion segment accounted for approximately 67.4% of the global external nasal dilator market share
The nasal congestion segment is expected to hold the largest market share over the forecast period. Nasal congestion occurs when the nasal passages and the tissues around them as well as blood vessels swell due to excessive fluids. The blocked nose condition comes from this irritation that also gives one a sense of complexation or closure in the nostrils. For infants who cannot be fed due to the congestion or children whose sleep is disturbed by it, a child's stuffy nose could be very distressing.
The more extended their nasal cavity is, the folks with blocked noses get immensely alleviated by that alone. For instance, Bausch Health Companies Inc. revealed on May 2023 that RYALTRIS, a new medication combining mometasone furoate nasal spray with olopatadine hydrochloride can now be found throughout Canada.
Health Canada has authorized RYALTRIS for symptomatic medical management of adults, adolescents, and children six years of age and above having mild to severe spring allergic sinusitis (SAR) with related vision problems. The need for external nasal dilators is rising along with the frequency of nasal congestion, which is fueling the expansion of the external nasal dilator market globally throughout the forecast period.
North America accounted for approximately 41.3% of the global external nasal dilator market share
North America region is expected to hold the largest market share over the forecast period due to the high frequency of long-term sinusitis, reputable suppliers, and rising knowledge of the advantages of external nasal dilatation over alternative techniques.
In the United States, obstructive sleep apnea will affect around 30 million persons by 2023. Roughly 80% of these cases go undetected, resulting in health care costs, decreased productivity at work, and workplace and auto accidents costing the United States more than $149 billion yearly.
Sleep problems can reduce productivity at work and have major health repercussions. According to CDC projections from August 2023, nearly one-third of adult Americans sleep fewer hours than recommended and sleep disorders represent a major public health emergency.
Additionally, the cost of healthcare has increased as a result of the growing prevalence of chronic diseases in North America. Due to the high prevalence of snoring, chronic sinusitis, and rhinosinusitis, North America is expected to have the highest revenue share in the global external nasal dilator market, which in turn drives the regional market during the forecast period.
The COVID-19 pandemic significantly impacted the global external nasal dilator market. The pandemic affected the manufacture and delivery of a variety of commodities, including medical equipment like nasal strips and external nasal dilators, by upsetting global supply networks.
It's possible that lockdowns, travel restrictions, and labor scarcity contributed to supply and manufacturing delays. There may have been changes in consumer behavior during the epidemic, such as a greater emphasis on wellness and health items. It's possible that some people have become more interested in devices like external nasal dilators to breathe easier and sleep better.
The major global players in the external nasal dilator market include GlaxoSmithKline Plc, SleepRight, Health Right Products LLC, Walmart Inc, Airware Labs, Walgreen Co, SHREYAAS HEALTH CARE PVT LTD, Nasilator, Rhinomed Limited, McKeon Products, Inc and among others.
The global external nasal dilator market report would provide approximately 70 tables, 66 figures, and 182 Pages.
Target Audience 2024